CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
JCI reported strong Q2 FY 26 results, with adjusted EPS of $1.19 surging 45% Y/Y and beating consensus by $0.07, while sales rose 8% to $6.14B (organic +6%). Adjusted EBIT margin expanded 310 bps to 15.5%, driven by strong volumes, favorable pricing, and productivity improvements, with particularly robust performance in EMEA and Asia-Pacific. The company's backlog reached $20.0B (+26% organically), fueled by a 30% organic surge in orders as customers accelerated investments in data center projects. Management raised FY 26 adjusted EPS guidance to ~$4.85 (from ~$4.70), above the $4.76 consensus, while lifting organic sales growth expectations to ~6% from mid-single digits previously. Despite the strong results, JCI shares declined 2% in pre-market trading as Q3 adjusted EPS guidance of ~$1.28 was merely in line with consensus. We believe continued momentum in data centers and building automation will drive growth, but we note the company's history of conservative guidance may have tempered investor enthusiasm.